Decisions / 4479
final resolution2020-10-01active

Arzneimittel-​​​Richtlinie/Anlage XII: Avelumab (Neubewertung nach Aufhebung des Orphan-Drug-Status: metastasiertes Merkelzellkarzinom)

Open official decision page ↗

G-BA source · retrieved 2026-08-05

Structured conclusion

Final result by patient group

1 source-verified result

Patient group

Erwachsene Patienten mit metastasiertem Merkelzellkarzinom (MCC); Erstlinientherapie:

Added benefit not proven

Comparator
Therapie nach Maßgabe des Arztes

Open official result PDF ↗

Decision orientation

What the G-BA did

4 cited claims

Each claim links to the official G-BA page or an exact PDF page range.

Official metadata

Decision date
2020-10-01
Effective
01.10.2020
Action type
final resolution
Committee
Arzneimittel

Case context

Listed normative targets

directiveArzneimittel-Richtlinie
directive annexAnlage XII: Nutzenbewertung nach § 35a SGB V

A listed target is not treated as a new directive version unless an official version source exists.

Official document package